Hermetica Superfood Encyclopedia
The Short Answer
Oleic acid, a monounsaturated omega-9 fatty acid comprising up to 53.58% of Atlantic salmon head oil, modulates plasma lipid profiles by suppressing hepatic VLDL synthesis, upregulating LDL receptor expression, and attenuating NF-κB-mediated inflammatory signaling. In normolipidemic subjects, diets enriched with oleic acid have been associated with reductions in total and LDL cholesterol and improvements in the LDL-to-HDL ratio, though effect magnitudes are modest compared to pharmaceutical interventions.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keywordsalmon oil oleic acid benefits
Salmon Oil Oleic Acid — botanical close-up
Health Benefits
**Cholesterol Profile Modulation**
Oleic acid reduces LDL cholesterol and total cholesterol concentrations in normolipidemic individuals by upregulating hepatic LDL receptor activity and suppressing VLDL secretion, with the LDL-to-HDL ratio improving more favorably than with saturated fat-enriched diets.
**Anti-Inflammatory Activity**
Oleic acid attenuates NF-κB pathway activation and reduces circulating pro-inflammatory cytokines including IL-6 and TNF-α, partly by competing with arachidonic acid for incorporation into cell membrane phospholipids and reducing eicosanoid precursor availability.
**Glucose Homeostasis and Insulin Sensitivity**
Oleic acid improves insulin receptor signaling by modifying membrane fluidity and phospholipid composition, enhancing GLUT4 translocation and reducing lipotoxicity-associated insulin resistance in peripheral tissues.
**Antioxidant and Cytoprotective Effects**
Salmon oil oleic acid, particularly when extracted via pressurized liquid extraction (PLE), demonstrates enhanced oxygen radical antioxidant capacity (ORAC) up to 4.5-fold greater than conventionally extracted oil, reducing oxidative stress biomarkers in cell-based models.
**Antiproliferative and Pro-Apoptotic Activity**
In vitro studies show oleic acid induces G0/G1 cell cycle arrest in tumor cell lines in a dose- and time-dependent manner, increasing expression of p53 and cleaved caspase-3 while downregulating CyclinD1 and Bcl-2, suggesting potential oncostatic properties.
**Cardiovascular Coagulation Modification**
Oleic acid alters platelet aggregation and blood coagulation properties by modifying membrane phospholipid composition and reducing thromboxane A2 synthesis relative to saturated fatty acids, contributing to a modestly antithrombotic milieu.
**Synergistic Omega-3 Support**
Within the broader salmon oil fatty acid matrix, oleic acid coexists with EPA and DHA (omega-3s comprising 19–21% of side-stream oil), α-linolenic acid, and palmitoleic acid, creating a complementary lipid environment that amplifies anti-inflammatory and lipid-regulatory outcomes beyond oleic acid alone.
Origin & History
Natural habitat
Oleic acid derived from salmon oil is sourced primarily from Atlantic salmon (Salmo salar), a species native to the North Atlantic Ocean and rivers of North America and Europe, with major aquaculture operations in Norway, Scotland, Chile, and Canada. Salmon oil is extracted from whole fish, heads, viscera, and soft tissue side streams generated during fish processing, with head oil yielding the highest oleic acid concentrations at approximately 53.58%. Commercial production leverages both wild-caught and farmed Atlantic salmon, with farmed fish representing over 70% of global salmon supply and providing a consistent, scalable source for oil extraction.
“Indigenous Arctic and subarctic peoples, including Inuit and First Nations communities of coastal North America and Scandinavia, have consumed salmon and rendered salmon oil as a primary dietary fat for thousands of years, using traditional cold-smoking, fermentation, and rendering techniques to preserve oil from salmon carcasses and heads. In traditional Norwegian and Scottish fishing communities, salmon processing waste including heads and viscera was historically rendered into lamp oil, animal feed, and medicinal preparations believed to support joint health and skin integrity, practices that predate the characterization of fatty acid composition. The epidemiological observation of low cardiovascular disease rates in fish-consuming Arctic populations, particularly Greenlandic Inuit studied by Bang and Dyerberg in the 1970s, catalyzed modern scientific interest in marine-derived fatty acids including the monounsaturated fraction of salmon oil. Contemporary research has reframed salmon oil side streams—historically discarded during commercial processing—as high-value functional ingredients, aligning with circular economy principles and elevating oleic acid from an overlooked component to a recognized bioactive contributor within the salmon oil matrix.”Traditional Medicine
Scientific Research
The evidence base for oleic acid from salmon oil specifically is predominantly preclinical, comprising in vitro cell culture studies and biochemical characterization of fatty acid profiles in Salmo salar tissues, with limited human clinical trials isolating salmon oil oleic acid as the primary intervention variable. Clinical evidence for oleic acid's cholesterol-lowering effects in normolipidemic subjects derives largely from dietary substitution studies—most notably the PREDIMED trial and its sub-analyses—which examined oleic acid within the context of olive oil rather than salmon oil, constraining direct extrapolation to the marine-derived source. In vitro antiproliferative data, while mechanistically detailed, has not been confirmed in human oncology trials, and the antioxidant superiority of pressurized liquid extraction over conventional methods has been demonstrated only in laboratory ORAC assays rather than in bioavailability or clinical outcome studies. Overall, the body of evidence for salmon oil oleic acid as a discrete supplement ingredient is preliminary, warranting cautious interpretation and emphasizing the need for dedicated randomized controlled trials with standardized salmon oil oleic acid preparations.
Preparation & Dosage
Traditional preparation
**Salmon Oil Softgel Capsules**
000 mg of total oil per capsule; at 39–54% oleic acid content, each capsule delivers approximately 390–540 mg oleic acid
Standard commercial salmon oil capsules typically provide 1,. Common supplemental regimens range from 1–3 g total salmon oil daily.
**Liquid Salmon Oil**
5 mL) of salmon oil provides approximately 2–3 g total fatty acids, with oleic acid contributing roughly 1–1
Consumed directly or added to food; 1 teaspoon (~.6 g per teaspoon depending on tissue source.
**Pressurized Liquid Extraction (PLE) Concentrates**
Research-grade and specialty extracts using PLE yield oils with enhanced antioxidant capacity (up to 4.5-fold higher ORAC); not yet widely standardized for consumer supplementation.
**Standardization**
No regulatory standard for minimum oleic acid percentage in salmon oil supplements currently exists; high-quality products should specify fatty acid profile via certificate of analysis, with head-derived oils expected to yield >50% oleic acid and soft tissue oils approximately 39%.
**Effective Dose for Lipid Effects**
3–6 g/day total oil are commonly employed in research contexts, though source-specific human dose-response data for salmon oil oleic acid are absent
Human dietary enrichment studies with oleic acid generally use 30–40% of total dietary fat as monounsaturated fatty acids; translating to supplemental salmon oil, doses of .
**Timing**
Taken with meals to optimize absorption via bile acid-mediated emulsification and micellar transport; split dosing (morning and evening meals) is commonly recommended in omega-rich oil supplementation protocols.
Nutritional Profile
Salmon oil (Salmo salar) is a lipid-dense extract providing approximately 900 kcal per 100 g, composed almost entirely of mixed fatty acids with negligible protein and carbohydrate content. Oleic acid (18:1n-9) is the dominant fatty acid, comprising 39.47–53.58% of total fatty acids depending on tissue source (soft tissue vs. head oil), followed by linoleic acid (omega-6, 14.56–15.43%), α-linolenic acid (omega-3, 4.46–5.91%), gondoic acid (omega-9, 20:1, 4.02–5.75%), and palmitoleic acid (omega-7, 1.39–3.24%). EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are present at lower concentrations in head and soft tissue oils compared to traditionally marketed salmon oil products due to tissue-specific partitioning, with omega-3s representing 19–21% of the broader side-stream oil fraction. Salmon oil also contains fat-soluble vitamins D3 and A, astaxanthin (a carotenoid antioxidant at trace concentrations), and CoQ10 analogs. Bioavailability of oleic acid from salmon oil is high when consumed with food, with micellar incorporation in the small intestinal lumen facilitating efficient absorption; re-esterification into chylomicrons and subsequent lymphatic transport are the primary delivery routes to systemic circulation.
How It Works
Mechanism of Action
Oleic acid (18:1n-9) exerts its primary lipid-regulatory effects by activating peroxisome proliferator-activated receptor alpha (PPARα) and liver X receptor (LXR) pathways, which collectively upregulate hepatic LDL receptor gene transcription and reduce VLDL particle assembly and secretion, thereby lowering circulating atherogenic lipoprotein concentrations. At the membrane level, oleic acid replaces saturated fatty acids in phospholipid bilayers, increasing membrane fluidity and enhancing insulin receptor conformational dynamics, which facilitates downstream IRS-1/PI3K/Akt signaling and GLUT4-mediated glucose uptake in skeletal muscle and adipose tissue. Its anti-inflammatory mechanism involves competitive inhibition of arachidonic acid incorporation into cell membrane phospholipids and partial suppression of COX-2 and 5-LOX enzyme activity, reducing synthesis of pro-inflammatory prostaglandins and leukotrienes while simultaneously modulating NF-κB nuclear translocation. The antiproliferative activity observed in vitro is mediated through p53 stabilization, upregulation of the pro-apoptotic effector caspase-3, and concurrent downregulation of the anti-apoptotic protein Bcl-2 and the G1-phase cell cycle regulator CyclinD1, inducing growth arrest and apoptosis in susceptible tumor cell populations.
Clinical Evidence
No large-scale, independently powered randomized controlled trials have specifically examined oleic acid from salmon oil in isolation as the primary intervention in human subjects; existing human evidence is derived from broader fish oil supplementation studies or oleic acid dietary enrichment trials using plant-based sources such as olive oil. Dietary substitution studies replacing saturated fats with oleic acid-rich oils have reported reductions in LDL cholesterol of approximately 5–10% and improvements in the total cholesterol-to-HDL ratio, with effect sizes considered modest but clinically meaningful in cardiovascular risk management for normolipidemic populations. Mechanistic and compositional studies confirm that Atlantic salmon head oil contains 53.58% oleic acid alongside complementary bioactives including omega-3 fatty acids (19–21%), supporting the hypothesis that the intact salmon oil matrix may provide synergistic cardiometabolic benefits beyond isolated oleic acid supplementation. Confidence in the cholesterol-modulating outcomes attributed specifically to salmon oil oleic acid remains low-to-moderate given the absence of source-specific human trials and the confounding presence of other bioactive fatty acids in whole salmon oil preparations.
Safety & Interactions
At supplemental doses of 1–6 g salmon oil daily, oleic acid and the broader fatty acid matrix are generally well tolerated in healthy adults, with the most common adverse effects being gastrointestinal in nature—including fishy aftertaste, burping, loose stools, and nausea—particularly when consumed on an empty stomach or at higher doses. Salmon oil, like other fish oils, may mildly inhibit platelet aggregation at higher doses (>3 g/day total omega-3 equivalents), and individuals taking anticoagulant or antiplatelet medications including warfarin, clopidogrel, or aspirin should use caution and consult a healthcare provider due to potential additive bleeding risk, though clinically significant interactions at standard supplemental doses are not well documented. Individuals with fish or salmon allergies should avoid salmon oil preparations, and those with lipid metabolism disorders or on lipid-lowering pharmacotherapy (statins, fibrates) should seek medical guidance before initiating supplementation, as the net lipid effects may require monitoring. Pregnancy and lactation: salmon oil consumption is generally considered safe in moderate amounts during pregnancy and lactation due to its beneficial fatty acid content; however, pregnant women should confirm sourcing quality to minimize exposure to heavy metals and persistent organic pollutants that may co-concentrate in marine oil products; no established maximum safe dose for salmon oil oleic acid specifically exists in regulatory guidance.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Salmo salar oilcis-9-octadecenoic acid18:1n-9omega-9 fatty acidmarine monounsaturated fatty acidAtlantic salmon oil
Frequently Asked Questions
How much oleic acid is in salmon oil compared to olive oil?
Atlantic salmon head oil contains approximately 53.58% oleic acid by total fatty acid content, while soft tissue salmon oil contains roughly 39.47%; by comparison, extra virgin olive oil typically contains 65–80% oleic acid. While olive oil is the richer source of oleic acid by percentage, salmon oil provides oleic acid alongside a complementary matrix of omega-3 fatty acids (EPA, DHA, ALA) not present in olive oil, potentially offering broader cardiometabolic benefits.
Can salmon oil oleic acid lower cholesterol in people with normal lipid levels?
In normolipidemic individuals, diets enriched with oleic acid from any source have been associated with modest but meaningful reductions in LDL cholesterol (approximately 5–10%) and improvements in the LDL-to-HDL ratio, primarily by upregulating hepatic LDL receptor expression and suppressing VLDL secretion. However, dedicated randomized controlled trials specifically using salmon oil as the oleic acid source in normolipidemic subjects are lacking, meaning these estimates extrapolate from broader dietary oleic acid research rather than salmon oil-specific clinical data.
What is the recommended dose of salmon oil for oleic acid benefits?
No standardized dosing protocol exists specifically for salmon oil oleic acid supplementation; general fish oil supplementation studies commonly use 1–6 g of total salmon oil daily, providing roughly 390 mg to over 3 g of oleic acid depending on oil source and tissue origin. Soft tissue salmon oil at 1,000 mg per capsule delivers approximately 390–540 mg oleic acid per capsule, and taking doses with meals optimizes absorption through bile acid emulsification. Individuals seeking lipid-modulating effects should consult a healthcare provider for personalized dosing guidance.
Is salmon oil oleic acid safe to take with blood thinners like warfarin?
Salmon oil, like other fish oils, contains fatty acids that may mildly inhibit platelet aggregation, particularly at higher doses exceeding 3 g per day of total oil; combining salmon oil with anticoagulants such as warfarin or antiplatelet drugs like clopidogrel could theoretically potentiate bleeding risk through additive effects on hemostasis. At standard supplemental doses of 1–3 g daily, clinically significant interactions are not well documented, but individuals on anticoagulation therapy should inform their physician before starting salmon oil supplementation and may require more frequent INR monitoring.
Does salmon oil oleic acid have anti-cancer properties?
In vitro studies have shown that oleic acid induces G0/G1 cell cycle arrest and apoptosis in tumor cell lines through a mechanism involving increased p53 and cleaved caspase-3 expression alongside decreased CyclinD1 and Bcl-2 levels, suggesting antiproliferative potential at the cellular level. However, these findings are exclusively from laboratory cell culture models and have not been validated in human clinical oncology trials; salmon oil oleic acid cannot currently be recommended as a cancer treatment or prevention strategy based on available evidence.
Does oleic acid from salmon oil affect omega-3 absorption or efficacy?
Oleic acid from salmon oil does not interfere with omega-3 fatty acid (EPA and DHA) absorption; in fact, the presence of oleic acid may enhance overall lipid absorption due to improved micelle formation in the digestive tract. Salmon oil naturally contains both oleic acid and omega-3s, and they work synergistically to support cardiovascular and inflammatory markers. The mixed fatty acid profile of salmon oil provides complementary benefits beyond what omega-3s alone would deliver.
Is oleic acid from salmon oil better absorbed when taken with food?
Oleic acid from salmon oil is a fat-soluble compound and is significantly better absorbed when consumed with dietary fat or a meal containing fat. Taking salmon oil supplements with meals—particularly those containing some dietary fat—enhances the bioavailability and lymphatic transport of oleic acid and other lipophilic nutrients. Empty stomach consumption can result in reduced absorption and increased gastrointestinal discomfort for some individuals.
Who would benefit most from supplementing with oleic acid from salmon oil specifically?
Individuals with elevated LDL cholesterol, metabolic syndrome, or chronic inflammatory conditions may benefit most from oleic acid-rich salmon oil supplementation due to its dual action on cholesterol metabolism and NF-κB inflammatory pathway suppression. Those seeking cardiovascular support without the side effects of statins, or individuals with limited access to quality dietary sources of oleic acid and omega-3s, are also good candidates. People with autoimmune or inflammatory bowel conditions may experience particular benefit from the combined anti-inflammatory profile of salmon oil's oleic acid content.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w oleic-acid-from-salmon-oil-salmo-salar curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
